Jim Cramer says the 'worst is over' at Salesforce, sees another 20% upside from here

Salesforce shares surged ~21% after the company delivered unexpectedly strong earnings and signaled revenue acceleration is arriving, supporting renewed investor confidence. The quarter showed continued traction in its new AI products (including Agentforce) and included guidance for the current period pointing to improving growth momentum. A new partnership/product with Anthropic (Claude “Claudeforce” plugin) helped ease AI-disruption fears. Jim Cramer called the worst over and suggested upside targets of $250 and potentially $300 (>$20% above Thursday’s levels).

Analysis

CRM’s move is less about one quarter than a regime change in how the market prices enterprise software: if management can show that AI is additive rather than cannibalistic, the stock can re-rate from “ex-growth incumbent” back toward a durable compounder. The first-order beneficiaries are CRM shareholders, but the second-order winner is the broader large-cap software complex if this quarter reduces the fear discount on seat-based models; that is most relevant for MSFT, ORCL, NOW, and to a lesser extent HUBS. The main loser is the basket of SaaS names whose multiples were propped up by the idea that workflow ownership alone was defensible against LLMs.

The move is likely strongest over the next 2-8 weeks if momentum/covering and event flow into Dreamforce keep forcing allocators back in. Over 1-3 months, the key question is whether the new AI usage translates into bookings, cRPO, and operating margin expansion rather than just demo activity. A hidden risk is that “AI integration” can become a margin tax: inference costs, partner rev-share, and implementation complexity can rise before seat expansion does, which would cap EPS upside even if revenue stabilizes.

The contrarian view is that the market may be mistaking narrative repair for fundamental acceleration. If the quarter simply confirms stabilization, the stock may have already discounted much of the recovery; the next leg higher requires evidence that AI features increase wallet share, not merely retention. Watch for any sign that customers are using Claude access to reduce licenses or push for pricing concessions—if net retention or guidance slips back, the post-earnings squeeze can unwind quickly.

GM and NKE are only indirect beneficiaries through improved enterprise workflow adoption, not a clean trade. The real alert is whether CRM can hold the post-gap above prior resistance; failure to retain most of the earnings gap would suggest the move is flow-driven rather than structurally de-rating the bear case.

Key Decisions for Investors

• Long CRM on pullbacks over the next 1-2 weeks; use the post-earnings gap as the risk reference. Upside is a momentum-driven re-rating into Dreamforce, but trim if the stock loses roughly half the gap or if volume fades on up-days.
• Buy CRM Nov/Dec call spreads instead of outright stock to express continuation into the September catalyst. The structure captures a 10-15% follow-through while limiting downside to premium if the AI narrative cools.
• Pair trade: long CRM / short a basket of fragile SaaS multiples (e.g., DDOG, HUBS) for 1-3 months. Thesis is that CRM has just proven AI can defend the model, while the market may still be overpricing smaller vendors with weaker platform moats.
• Watch the next print for cRPO, net retention, and operating margin, not just revenue beats. If bookings do not accelerate and margins absorb AI partner costs, de-rate the bull case and consider fading strength.
• If CRM approaches the low-$300s without a follow-through in guidance, consider taking profits; that would imply the market has re-rated on sentiment ahead of fundamentals.